- Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
-
Oh J, Joo KW, Chin HJ, Chae DW, Kim SG, Kim SJ, Chung W, Kim S, Huh W, Oh HY, Choi BS, Yang CW, Kim S
- KMID: 1796918
- J Korean Med Sci.
- 2014 Jan;29(1):76-83.
- doi: 10.3346/jkms.2014.29.1.76
Continuous erythropoietin receptor activator (CERA) is an erythropoietin with a long-half life. This study investigated the efficacy of CERA for correcting anemia in Korean patients on dialysis. Patients (> or... -
- CITED
-
- Close
- SHARE
-
- Close
